BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 8079303)

  • 1. [Mass vaccination against tuberculosis--is it necessary in Norway?].
    Eskild A
    Tidsskr Nor Laegeforen; 1994 Jun; 114(16):1840-4. PubMed ID: 8079303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries.
    Brantsaeter AB; Romanus V; Andersen PH; Heldal E
    Int J Tuberc Lung Dis; 2009 Apr; 13(4):440-5. PubMed ID: 19335948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Where do we stand with BCG vaccination programme in Japan?].
    Mori T
    Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six years' experience with the discontinuation of BCG vaccination. 2. Cost and benefit of mass BCG vaccination.
    Trnka L; Danková D; Svandová E
    Tuber Lung Dis; 1993 Aug; 74(4):288-92. PubMed ID: 8219182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Policy program to minimize spread of infection. Prolonged cough may be a sign of tuberculosis].
    Fredlund H; Larsson LO; Blom-Bülow B; Julander I; Normann B; Romanus V; Wahlström H
    Lakartidningen; 1998 Mar; 95(10):1010-2, 1015-6. PubMed ID: 9528251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contemporary status of BCG vaccine in the world and in Serbia].
    Pesut D
    Med Pregl; 2004; 57 Suppl 1():37-40. PubMed ID: 15686220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tuberculosis control in Scandinavia].
    Romanus V; Tala E; Blöndal T; Heldal E; Poulsen S
    Nord Med; 1995; 110(2):45-7. PubMed ID: 7854909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six years' experience with the discontinuation of BCG vaccination. 1. Risk of tuberculosis infection and disease.
    Trnka L; Danková D; Svandová E
    Tuber Lung Dis; 1993 Jun; 74(3):167-72. PubMed ID: 8369510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology of childhood tuberculosis in the Basque Autonomous Community 1980-89. Efficacy of BCG vaccination].
    Errezola Saizar M; Arístegui Fernández J; Gutiérrez Villamayor C; Pérez Díaz L; Zubillaga Huici P
    An Esp Pediatr; 1992 Mar; 36(3):177-80. PubMed ID: 1580424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccine prophylaxis of tuberculosis: implication and problems].
    Aksenova VA; Levi DT; Fonina EV; Vundtsettel' NN
    Probl Tuberk Bolezn Legk; 2009; (1):10-6. PubMed ID: 19253677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mass vaccination against tuberculosis--do we need it in Norway?].
    Skarpaas IJ
    Tidsskr Nor Laegeforen; 1994 Sep; 114(23):2751. PubMed ID: 7998020
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment.
    Altes HK; Dijkstra F; Lugnèr A; Cobelens F; Wallinga J
    Epidemiology; 2009 Jul; 20(4):562-8. PubMed ID: 19295437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The place of BCG vaccination in the fight against tuberculosis].
    Sickenga FN
    Ned Tijdschr Geneeskd; 1969 Jun; 113(25):1107-11. PubMed ID: 5791970
    [No Abstract]   [Full Text] [Related]  

  • 15. BCG and prospects for new vaccines against tuberculosis.
    Ortona L; De Luca A
    Rays; 1998; 23(1):225-30. PubMed ID: 9673148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis: vaccines in the pipeline.
    Ly LH; McMurray DN
    Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of BCG vaccination policy in Europe: 1994-96.
    Trnka L; Dankova D; Zitova J; Cimprichova L; Migliori GB; Clancy L; Zellweger JP
    Bull World Health Organ; 1998; 76(1):85-91. PubMed ID: 9615500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
    Araujo Z; de Waard JH; de Larrea CF; Borges R; Convit J
    Vaccine; 2008 Oct; 26(44):5575-81. PubMed ID: 18723065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective BCG vaccination in a country with low incidence of tuberculosis.
    Romanus V
    Euro Surveill; 2006; 11(3):14-7. PubMed ID: 16567880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.